Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cilta-cel', 'cartitude-4', 'mmsm', 'cartitude']
 lba - cartitude-4 cilta-cel vs pvd or dpd in patients with 1-3 prior lines
median follow-up 15.9 months #asco23 #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma